Clinical Trials Browser

Phase 1 × Not yet recruiting × Myasthenia Gravis × Clear all

NCT06978738 2025-05-18

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Phase 1 Not yet recruiting

Classical hematology

Immunoglobulin G4-Related Disease, Anemia, Hemolytic, Autoimmune, Lupus Erythematosus, Systemic, Myasthenia Gravis, Myositis, Scleroderma, Systemic, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

NCT06958939 2025-05-06

The Safety and Efficacy of S103 in the Treatment of Refractory Generalized Myasthenia Gravis

Phase 1 Not yet recruiting

Myasthenia Gravis

NCT06759948 2025-01-06

KY2024-853

Phase 1 Not yet recruiting

Myasthenia Gravis